BioMarin Pharmaceutical Inc. (BMRN) - Earnings & Price History

BMRN: BioMarin Pharmaceutical Inc. - 88, $15.36B, 0.67 (0.77%)

Sector: Healthcare - Industry: Biotechnology

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), an inherited metabolic disease; Aldurazyme used for the treatment of patients with mucopolysaccharidosis I, a genetic disease; and Firdapse, a form of 3,4-diaminopyridine used for the treatment of Lambert Myasthenic Syndrome, an autoimmune disease. The company also conducts clinical trials on several investigational product candidates for the treatment of various diseas

Past BMRN reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-23-0.3887.5189.2987.9985.8888.82-1.46%-0.55%-1.99%1.47M
2016-10-27-0.3981.1381.0279.7378.5683.32-1.59%1.76%0.14%1.92M
2016-08-04-0.5298.9499.62100.8898.5101.671.26%-1.92%-0.68%2.08M
2016-04-28AMC-0.7984.6885.183.4483.0287.5-1.95%▲1.49%-0.49%1.70M
2016-02-25AMC0.9980.1476.4174.874.882.11-2.11%7.14%4.88%2.29M
2015-10-29AMC-0.65117.04113.8111.66110118.48-1.88%4.82%2.85%2.14M
2015-08-03AMC-0.53143.78147.17145141.92147.76-1.47%-0.84%-2.30%1.62M
2015-04-30AMC-0.53115.92112.05114.85112.61119.752.50%▲0.93%3.45%1.86M
2015-02-25AMC-0.59108.84107.5108.25104.96111.890.70%0.55%1.25%1.95M
2014-10-23AMCBiomarin Pharma-0.22-0.1681.0375.0175.475.481.830.52%7.47%8.03%2.40M
2014-07-30AMCBiomarin Pharma-0.42-0.1961.8261.0964.861.265.996.07%-4.60%1.19%3.99M
2014-05-01AMCBiomarin Pharma-0.5-0.2757.760.315855.560.2-3.83%▲-0.52%-4.33%3.57M
2014-03-03BMOBiomarin Pharma-0.34-0.2779.728180.1979.1781.44-1.00%-0.59%-1.58%1.16M
2013-10-24AMCBiomarin Pharma-0.28-0.3866.2468.9667.5865.668-2.00%-1.98%-3.94%3.11M
2013-07-25AMCBiomarin Pharma-0.28-0.1663.9163.8262.9662.0164.78-1.35%1.51%0.14%843.80K
2013-04-25AMC-0.363.1862.8762.6962.164.704-0.29%▲0.78%0.49%1.30M
2013-02-21AMC-0.2756.153.2753.3853.3556.210.21%5.10%5.31%2.65M
2012-10-25AMC-0.238.8538.1539.8838.395404.53%-2.58%1.83%3.22M
2012-08-01AMCQ2 2012 BioMarin Pha-0.21-0.2737.2438.0238.4436.9139.191.10%-3.12%-2.05%1.68M
2012-04-26AMCQ1 2012 BioMarin Pha-0.14-0.2135.0635.334.6633.7535.36-1.81%▲1.15%-0.68%943.60K
2012-02-16AMCQ4 2011 Biomarin Pha-0.11-0.2336.237.735.8535.1637.17-4.91%0.98%-3.98%2.46M
2011-10-27AMCQ3 2011 Biomarin Pha-0.11-0.1435.3833.2633.2232.5535.56-0.12%6.50%6.37%1.66M
2011-07-28AMCQ2 2011 Biomarin Pha-0.11-0.0531.2329.2930.8929.6131.685.46%1.10%6.62%1.86M
2011-04-28AMCQ1 2011 BioMarin Pha-0.1-0.0426.8926.4626.6426.4126.980.68%▲0.94%1.63%689.00K
2011-02-17AMCQ4 2010 BioMarin Pha-0.020.0127.2328.2926.7426.5127.65-5.48%1.83%-3.75%2.85M
2010-10-28AMCQ3 2010 BioMarin Pha-0.011.6826.1124.6224.8224.6826.170.81%5.20%6.05%1.91M
2010-08-02AMCQ2 2010 BioMarin Pha0.03-0.0121.4921.982120.7521.83-4.46%2.33%-2.23%1.28M
2010-04-29Q1 2010 BioMarin Pha0.0123.3723.3623.322.0523.56-0.26%▲0.30%0.04%2.34M
2010-02-23AMCQ4 2009 BioMarin Pha0.010.0520.0520.2220.5519.9320.551.63%-2.43%-0.84%1.01M
2009-10-28AMCQ3 2009 BioMarin Pha0.010.0615.4915.6817.5615.4517.8811.99%-11.79%-1.21%4.12M
2009-07-30AMCQ2 2009 BioMarin Pha-0.010.0116.4114.8115.091516.411.89%8.75%10.80%3.63M
2009-04-30AMCQ1 2009 BioMarin Pha-0.12-0.1313.6912.8612.8512.6614.8-0.08%▲6.54%6.45%3.75M
2009-02-18Q4 2008 BioMarin Pha0.260.2112.0417.6913.3511.8213.4-24.53%-9.81%-31.94%30.04M
2008-10-28AMCQ3 2008 BioMarin Pha0.030.0118.0115.3115.3315.0118.40.13%17.48%17.64%4.19M
2008-08-05AMCQ2 2008 BioMarin Pha0.030.0430.131.728.362830.6-10.54%6.14%-5.05%11.57M
2008-04-29AMCQ1 2008 BioMarin Pha-0.050.0236.4633.7735.5235.5236.865.18%▲2.65%7.97%7.69M
2008-02-26AMCQ4 2007 BioMarin Pha0.040.0339.6738.1137.537.0139.9-1.60%5.79%4.09%3.55M
2007-11-01AMCQ3 2007 BioMarin Pha-0.1-0.0527.6627.1827.5726.8228.591.43%0.33%1.77%2.47M
2007-08-07Q2 2007 BioMarin Pha-0.06-0.0420.9819.8319.919.8521.540.35%5.43%5.80%6.82M
2007-04-30AMCQ1 2007 BioMarin Pha-0.11-0.116.4116.1616.416.2916.561.49%▲0.06%1.55%2.52M
2007-02-20BMOQ4 2006 BioMarin Pha-0.13-0.111820.4516.9516.518.68-17.11%6.19%-11.98%11.86M
2006-11-01AMCQ3 2006 BioMarin Pha-0.13-0.0816.3115.7115.8615.716.670.95%2.84%3.82%1.49M
2006-08-02AMCQ2 2006 BioMarin Pha-0.11-0.0215.5414.4214.9814.5815.553.88%3.74%7.77%3.68M
2006-05-03AMCQ1 2006 BioMarin Pha-0.21-0.1313.0312.0312.1712.1713.241.16%▲7.07%8.31%1.64M
2006-02-23Q4 2005 BioMarin Pha-0.22-0.212.9212.1812.0612.0413.26-0.99%7.13%6.08%1.22M
2005-11-02BMOQ3 2005 BioMarin Pha-0.28-0.219.18.148.288.179.121.72%9.90%11.79%872.30K
2005-08-02BMOQ2 2005 BioMarin Pha-0.35-0.338.138.558.448.078.64-1.29%-3.67%-4.91%848.80K
2005-05-05AMCQ1 2005 BioMarin Pha-0.356.366.36.255.96.43-0.79%▲1.76%0.95%716.20K
2005-02-23BMOQ4 2004 BioMarin Pha5.265.065.044.995.73-0.40%4.37%3.95%553.00K
2004-11-03BMOQ3 2004 BioMarin Pha3.993.974.083.944.22.77%-2.21%0.50%416.90K
2004-08-10AMCQ2 2004 BioMarin Pha4.784.854.84.734.9-1.03%-0.42%-1.44%386.20K
2004-05-04BMOQ1 2004 BioMarin Pha6.386.376.396.026.50.31%▲-0.16%0.16%1.09M
2004-02-03Q4 2003 BioMarin Pha8.18.168.157.978.3-0.12%-0.61%-0.74%1.05M
2003-11-04Q3 2003 BioMarin Pha7.117.257.377.350.69%-2.60%-1.93%385.40K
2003-08-05BMOQ2 2003 BioMarin Pha8.19.769.87.889.90.41%-17.35%-17.01%4.07M
2003-05-05BMOQ1 2003 BioMarin Pha11.511.6211.6111.411.75-0.09%▲-0.95%-1.03%1.02M
2002-10-31BMOQ3 2002 BioMarin Pha6.456.696.676.366.88-0.30%-3.30%-3.59%395.30K
2002-08-01BMOQ2 2002 BioMarin Pha4.244.454.74.244.75.62%-9.79%-4.72%312.50K
2002-05-07BMOQ1 2002 BioMarin Ear5.645.585.455.455.77-2.33%▲3.49%1.08%88.00K
2002-02-25BMOBioMarin Q4 and Year10.311.311.2210.2611.26-0.71%-8.20%-8.85%423.60K
2001-10-26BMOQ3 2001 BioMarin Pha11.6511.0611.1411.0611.90.72%4.58%5.33%257.30K
2001-07-27BMOQ2 2001 BioMarin Pha11.911.9911.511.4912.18-4.09%3.48%-0.75%56.20K
2001-04-26AMCQ1 2001 BioMarin Pha10.261010.0410.0410.50.40%▲2.19%2.60%13.90K
2001-02-22BMOQ4 2000 BioMarin Pha98.629.258.629.257.31%-2.70%4.41%38.20K
2000-10-30BMOQ3 2000 BioMarin Pha12.51313.1912.3813.191.46%-5.23%-3.85%20.40K
2000-07-28BMOQ2 2000 BioMarin Pha18.752119.3818.5219.56-7.71%-3.25%-10.71%38.20K
2000-04-28BMOBioMarin Pharmaceuti17.8120.0620.0617.8120.06-11.22%-11.22%56.90K
2000-02-18BMOBioMarin Pharmaceuti1919.1218.6218.6219.5-2.62%2.04%-0.63%59.60K
1999-11-01BMOBiomarin Pharmaceuti15.3815.3815.751515.752.41%-2.35%12.50K
1999-08-17Biomarin Pharmaceuti141414.311414.312.21%-2.17%1.70K

Login | Register
Monday May 29, 2017   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY241.71-0.05-0.02%46,629,905

Upgrades/Downgrades